|
Market Cap (5-Jul) $277,062,656 (480th) |
Close (30-Jun) $3.40 |
Volume (30-Jun) 0 |
Shortsold (6-Aug) 667 (0.00%) (670th) |
|
52w High $3.12 |
52w Low $2.13 |
P/E 22.37 |
EPS 0.1 |
AFP released this announcement to the ASX on 8 April 2022, 7:32. The announcement is marked as price sensitive, and is 2 page(s) in length and 121.01kb in size.
You can view all announcements from AFP and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from AFP | |
|---|---|
| Notice of Annual Meeting of Shareholders 2023 | 30 June 2023, 7:30 |
| Dividend/Distribution - AFP | 30 May 2023, 14:13 |
| Annual Meeting and Closing Date for Director Nominations | 26 May 2023, 14:58 |
| AFT prevails in comparative advertising judgement | 8 April 2022, 7:32 |
| AFT notes FDA approval for Pascomer alternative | 5 April 2022, 11:18 |
| FFC: Farmaforce and AFT Pharmaceuticals Partnership | 23 February 2022, 13:30 |
| Disclosure of Directors & Senior Managers Relevant Interests | 13 January 2022, 8:37 |
You must be logged in to post a reply.
AFT Pharmaceuticals 